These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
446 related items for PubMed ID: 18813767
1. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection. Roselino AM, Chociay MF, Costa RS, Machado AA, Figueiredo JF. Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767 [Abstract] [Full Text] [Related]
2. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses. Zijlstra EE. PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435 [Abstract] [Full Text] [Related]
3. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report. Lindoso JAL, Moreira CHV, Celeste BJ, Oyafuso LKM, Folegatti PM, Zijlstra EE. Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829 [Abstract] [Full Text] [Related]
4. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans. Sreenivas G, Raju BV, Singh R, Selvapandiyan A, Duncan R, Sarkar D, Nakhasi HL, Salotra P. J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036 [Abstract] [Full Text] [Related]
5. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy. Gelanew T, Amogne W, Abebe T, Kuhls K, Hailu A, Schönian G. Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449 [Abstract] [Full Text] [Related]
6. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis. Hasnain G, Shomik MS, Ghosh P, Rashid MO, Hossain S, Hamano S, Mondal D. Am J Trop Med Hyg; 2016 Dec 07; 95(6):1383-1385. PubMed ID: 27672208 [Abstract] [Full Text] [Related]
7. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions. Sreenivas G, Ansari NA, Kataria J, Salotra P. J Clin Microbiol; 2004 Apr 07; 42(4):1777-8. PubMed ID: 15071047 [Abstract] [Full Text] [Related]
8. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report. Carnaúba D, Konishi CT, Petri V, Martinez IC, Shimizu L, Pereira-Chioccola VL. Int J Infect Dis; 2009 Nov 07; 13(6):e504-7. PubMed ID: 19447660 [Abstract] [Full Text] [Related]
10. An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection. Elliott T, Simpson J, Naresh KN, Lockwood D, Bailey AC. Int J STD AIDS; 2019 Oct 07; 30(12):1221-1223. PubMed ID: 31558131 [No Abstract] [Full Text] [Related]
13. Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia. Gelanew T, Hurissa Z, Diro E, Kassahun A, Kuhls K, Schönian G, Hailu A. Am J Trop Med Hyg; 2011 Jun 07; 84(6):906-12. PubMed ID: 21633027 [Abstract] [Full Text] [Related]
14. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients. Sarraf NR, Mukhopadhyay S, Banerjee A, Das AK, Roy S, Chakrabarti S, Manna M, Saha P. Acta Trop; 2021 Nov 07; 223():106086. PubMed ID: 34389331 [Abstract] [Full Text] [Related]
15. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review. Trindade MA, Silva LL, Braz LM, Amato VS, Naafs B, Sotto MN. BMC Infect Dis; 2015 Nov 23; 15():543. PubMed ID: 26592919 [Abstract] [Full Text] [Related]
16. Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis? Nandy A, Addy M, Maji AK, Guha SK. Ann Trop Med Parasitol; 2004 Sep 23; 98(6):651-4. PubMed ID: 15324473 [No Abstract] [Full Text] [Related]
17. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh. Nasreen SA, Hossain MA, Paul SK, Mahmud MC, Ahmed S, Ghosh S, Kobayashi N. Jpn J Infect Dis; 2012 Jul 23; 65(4):315-7. PubMed ID: 22814154 [Abstract] [Full Text] [Related]
18. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, Ramesh V, Negi NS. J Clin Microbiol; 2001 Mar 23; 39(3):849-54. PubMed ID: 11230394 [Abstract] [Full Text] [Related]
19. Post-Kala-azar dermal leishmaniasis due to Leishmania donovani in Europe--case report. Antunes J, da Costa JB, Guimarães M, Vaz-Pinto I, Soares-Almeida L, Filipe P. Int J Dermatol; 2013 Dec 23; 52(12):1584-6. PubMed ID: 24261735 [No Abstract] [Full Text] [Related]
20. The immunology of post-kala-azar dermal leishmaniasis (PKDL). Zijlstra EE. Parasit Vectors; 2016 Aug 23; 9(1):464. PubMed ID: 27553063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]